Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells

Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment

(2012) Kosuke Akiyama et al.   AMERICAN JOURNAL OF PATHOLOGY

Heterogeneity of Tumor Endothelial Cells

(2012) Noritaka Ohga et al.   AMERICAN JOURNAL OF PATHOLOGY

Renal Accumulation of Biglycan and Lipid Retention Accelerates Diabetic Nephropathy

(2011) Joel Thompson et al.   AMERICAN JOURNAL OF PATHOLOGY

HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium

(2011) T Kurosu et al.   BRITISH JOURNAL OF CANCER

Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells

(2011) Chikara Muraki et al.   INTERNATIONAL JOURNAL OF CANCER

Deficiency of Biglycan Causes Cardiac Fibroblasts to Differentiate into a Myofibroblast Phenotype

(2011) Ariane Melchior-Becker et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Isolated tumor endothelial cells maintain specific character during long-term culture

(2010) Kohei Matsuda et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration

(2010) K. Grote et al.   BLOOD

Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

(2010) Xiaoxia Z. West et al.   NATURE

Glioblastoma stem-like cells give rise to tumour endothelium

(2010) Rong Wang et al.   NATURE

Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors

(2009) Tomoshige Akino et al.   AMERICAN JOURNAL OF PATHOLOGY

Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells

(2009) Noritaka Ohga et al.   CANCER SCIENCE

Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors

(2009) Andrea Babelova et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction

(2008) D. Westermann et al.   CIRCULATION